Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07CQJ
|
||||
Former ID |
DIB000212
|
||||
Drug Name |
F-50040
|
||||
Synonyms |
Metastatic melanoma vaccine, Pierre Fabre; P40-ELA; Metastatic melanoma vaccine, BioMerieux-Pierre Fabre; Vaccine (melanoma), Pierre Fabre; Vaccine (melanoma), BioMerieux-Pierre Fabre
|
||||
Indication | Melanoma [ICD9: 172; ICD10:C43] | Discontinued in Phase 1 | [547414] | ||
Company |
Pierre Fabre SA
|
||||
Target and Pathway | |||||
Target(s) | MART-1 melanoma antigen | Target Info | Modulator | [526271] | |
Toll-like receptor 2 | Target Info | Modulator | [526271] | ||
KEGG Pathway | Phagosome | ||||
PI3K-Akt signaling pathway | |||||
Toll-like receptor signaling pathway | |||||
Legionellosis | |||||
Leishmaniasis | |||||
Chagas disease (American trypanosomiasis) | |||||
Malaria | |||||
Toxoplasmosis | |||||
Amoebiasis | |||||
Tuberculosis | |||||
Hepatitis B | |||||
Measles | |||||
Herpes simplex infection | |||||
Proteoglycans in cancer | |||||
Inflammatory bowel disease (IBD) | |||||
Rheumatoid arthritis | |||||
NetPath Pathway | IL4 Signaling Pathway | ||||
TCR Signaling Pathway | |||||
PANTHER Pathway | Toll receptor signaling pathway | ||||
Pathway Interaction Database | Endogenous TLR signaling | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.